Back
JPMorgan Chase & Vs. Monopar Therapeutics Industry Stock Comparison
Buy
67
JPM
JPMorgan Chase &
Last Price:
$254.35
Seasonality Move:
2.08%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.64
Seasonality Move:
-13.48%
Buy
67
JPMorgan Chase & (JPM)
is a Buy
Is JPMorgan Chase & a Buy, Sell or Hold?
-
The current JPMorgan Chase & [JPM] share price is $251.13. The Score for JPM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.58. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JPM Stock Price Chart
What is JPMorgan Chase &'s stock price today?
-
The JPMorgan Chase & share price today is $251.13Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.58The current trend is moderately bullish and MNPR is experiencing slight buying pressure.
JPM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.74 | Sell |
| Relative Strength Index (14 RSI): | 54.53 | Buy |
| Chaikin Money Flow: | 6006066 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (234.67 - 266.17) | Buy |
| Bollinger Bands (100): | (233.09 - 263.07) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 53.13 | Buy |
| Chaikin Money Flow: | 5727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.91 - 40.59) | Buy |
| Bollinger Bands (100): | (18.9 - 39.02) | Buy |
JPM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 240.04 | Buy |
| 20-day SMA: | 244.68 | Buy |
| 50-day SMA: | 256.97 | Sell |
| 200-day SMA: | 228.65 | Buy |
| 8-day EMA: | 242.91 | Buy |
| 20-day EMA: | 245.85 | Buy |
| 50-day EMA: | 250.23 | Buy |
| 200-day EMA: | 230.55 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Buy |
| 20-day SMA: | 33.43 | Buy |
| 50-day SMA: | 36.97 | Buy |
| 200-day SMA: | 16.52 | Buy |
| 8-day EMA: | 37.22 | Buy |
| 20-day EMA: | 36.12 | Buy |
| 50-day EMA: | 34.54 | Buy |
| 200-day EMA: | 21.18 | Buy |
JPMorgan Chase & Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.35 per share, a decrease this year of $0.06 per share, and an increase next year of $1.32 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
JPMorgan Chase & Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||